Alex Thurman
Directeur Financier/CFO chez GLAUKOS CORPORATION
Fortune : 5 M $ au 30/04/2024
Postes actifs de Alex Thurman
Sociétés | Poste | Début | Fin |
---|---|---|---|
GLAUKOS CORPORATION | Directeur Financier/CFO | 01/04/2022 | - |
Directeur Administratif | 01/07/2016 | 01/12/2016 | |
Comptroller/Controller/Auditor | 01/07/2016 | 01/12/2016 | |
Corporate Officer/Principal | 01/12/2016 | 01/04/2022 | |
ALLERGAN PLC | Directeur Financier/CFO | 01/12/2016 | - |
Historique de carrière de Alex Thurman
Formation de Alex Thurman
Brigham Young University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Irlande | 2 |
Opérationnelle
Director of Finance/CFO | 2 |
Chief Administrative Officer | 1 |
Comptroller/Controller/Auditor | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
GLAUKOS CORPORATION | Health Technology |
Entreprise privées | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- Alex Thurman
- Expérience